NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.
NEW YORK, NY / ACCESSWIRE / October 8, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (NASDAQ: PETQ ), relating to its proposed merger with Bansk Group.
NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.
| - Industry | - Sector | Mr. McCord Christensen CEO | NASDAQ (NGS) Exchange | 71639T106 CUSIP |
| US Country | 1,121 Employees | - Last Dividend | - Last Split | 21 Jul 2017 IPO Date |
PetIQ, Inc. operates as a comprehensive pet medication and wellness company, serving the needs of pets and their owners across the United States and internationally. Since its inception in 2010, with headquarters in Eagle, Idaho, PetIQ, Inc. has grown into a multi-faceted enterprise. It functions through two main segments, Products and Services, providing an extensive range of pet healthcare solutions. The company is dedicated to improving the well-being of pets by offering affordable and accessible veterinary care and wellness products. By operating through veterinarian, retail, and e-commerce channels, PetIQ, Inc. has established a significant footprint in the pet health industry.
PetIQ offers a broad selection of prescription medications for pets, including treatments for flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes, pain, antibiotics, and other specialty medications. These products are vital for pet owners looking to maintain the health and happiness of their pets with pharmaceutical care.
The company not only develops and manufactures its proprietary value-branded products but also provides third-party branded products for dogs and cats. This includes a mix of medically necessary and wellness products, ensuring a comprehensive range of options for pet health and care.
Over-the-counter (OTC) medications and supplies offered by PetIQ cover a wide spectrum, including flea and tick control, dog dewormers, and behavior management solutions. These products come in various forms such as spot-on treatments, chewables, oral tablets, and collars, catering to the diverse needs of pet owners for non-prescription care solutions.
Under brands like PetArmor®, Rocco & Roxie®, VetIQ®, Minties®, and Sentry®, PetIQ provides health and wellness products including dog and cat treats, oral health solutions, stain and odor treatments, and nutritional supplements. These products are essential for maintaining the general well-being, nutritional health, and hygiene of pets.
PetIQ operates a veterinarian service platform that offers cost-effective and convenient veterinary wellness services through community clinics, pop-up locations, wellness centers, and permanent locations. Services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks, facilitating comprehensive veterinary care for pets.